Regulatory T cells for immunotherapy of autoimmune diseases: from the bench to the bedside

Bibliography

• RONCAROLO MG, LEVINGS MK, TRAVERSARI C: Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. (2001) 193:F5–F9.
   PubMed Web of Science ®Google Scholar
• VON HERRATH MG, HARRISON LC: Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol (2003) 3:223–232.
   PubMed Web of Science ®Google Scholar
• JONULEIT H, SCHMITT E: The regulatory Teell family: distinct subsets and their interrelations. J. Immunol (2003) 171:6323–6327.
   PubMed Web of Science ®Google Scholar
• STEINMAN RM, HAWIGER D, NUSSENZWEIG MC: Tolerogenic dendritic cells. Ann. Rev. Immunol (2003) 21:685–711.
   PubMed Web of Science ®Google Scholar
• ••A fundamental review on the biology oftolerogenic DCs.
   Google Scholar
• MORELLI AE, THOMSON AW: Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev. (2003) 196:125–146.
   PubMed Web of Science ®Google Scholar
• WEINER HL: Induction and mechanism of action of transforming growth factor-13-secreting TH3 regulatory cells. Immunol Rev. (2001) 182:207–214.
   PubMed Web of Science ®Google Scholar
• BLUESTONE JA: Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol (2005) 5:343–349.
   Google Scholar
• ••A comprehensive and interesting review ontranslational immunology.
   Google Scholar
• GROUX H, O'GARRA A, BIGLER M et al.: A CD4*T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737–742.
   Google Scholar
• BACCHETTA R, BIGLER M, TOURAINE JL et al.: High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells. J. Exp. Med. (1994) 179:493–502.
   PubMed Web of Science ®Google Scholar
• •The first report on IL-10-producing Treg cells.
   Google Scholar
• RONCAROLO MG, BACCHETTA R, BORDIGNON C, NARULA S, LEVINGS MK: Type 1 T regulatory cells. Immunol Rev. (2001) 182:68–79.
   PubMed Web of Science ®Google Scholar
• ZELENIKA D, ADAMS E, HUMM S et al. Regulatory T cells overexpress a subset of TH2 gene transcripts. J. Immunol (2002) 168:1069–1079.
   PubMed Web of Science ®Google Scholar
• COBBOLD SP, NOLAN KF, GRACA L et al.: Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev. (2003) 196:109–124.
   PubMed Web of Science ®Google Scholar
• LEVINGS MK, SANGREGORIO R, GALBIATI F, SQUADRONE S, DE WAAL MALEFYT R, RONCAROLO MG: IFN-a and IL-10 induce the differentiation of human Type 1 T regulatory cells. J. Immunol. (2001) 166:5530–5539.
   PubMed Web of Science ®Google Scholar
• KEMPER C, CHAN AC, GREEN JM, BRETT KA, MURPHY KM, ATKINSON JP: Activation of human CD4* cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature (2003) 421:388–392.
   PubMed Web of Science ®Google Scholar
• CHEN Z, O'SHAUGHNESSY MJ, GRAMAGLIA I et al.: IL-10 and TGF-13 induce alloreactive CD4*CD25- T cells to acquire regulatory cell function. Blood (2003) 101:5076–5083.
   Google Scholar
• VIEIRA P, CHRISTENSEN JR, MINAEE S et al: IL-10-secreting regulatory T cells do not express FoxP3 but have comparable regulatory function to naturally occurring CD4*CD25* regulatory T cells. J. Immunol (2004) 172:5986–5993.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, LEMOLI RM: Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett. (2004) 94:11–26.
   PubMed Web of Science ®Google Scholar
• MOORE KW, DE WAAL MALEFYT R, COFFMAN RL, O'GARRA A: Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol (2001) 19:683–765.
   PubMed Web of Science ®Google Scholar
• BRADY MS, ECKELS DD, LEE F, REE SY, LEE JS: Cytokine production by CD4* T cells responding to antigen presentation by melanoma cells. Melanoma Res. (1999) 9:173–180.
   PubMed Web of Science ®Google Scholar
• YUDOH K, MATSUNO H, NAKAZAWA F, YONEZAWA T, KIMURA T: Reduced expression of the regulatory CD4* T cell subset is related to TH1/TH2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum. (2000) 43:617–627.
   PubMed Web of Science ®Google Scholar
• JONULEIT H, SCHMITT E, STASSEN M, TUETTENBERG A, KNOP J, ENK AH: Identification and functional characterization of human CD4*CD25* T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. (2001) 193:1285–1294.
   PubMed Web of Science ®Google Scholar
• DIECKMANN D, PLOTTNER H, BERCHTOLD S, BERGER T, SCHULER G: Ex vivo isolation and characterization of CD4*CD25* T cells with regulatory properties from human blood. J. Exp. Med. (2001) 193:1303–1310.
   PubMed Web of Science ®Google Scholar
• LEVINGS MK. SANGREGORIO R, SARTIRANA C et al.: Human CD25*CD4* T suppressor cell clones produce transforming growth factor 13, but not interleukin 10, and are distinct from Type 1 T regulatory cells. J. Exp. Med. (2002) 196:1335–1346.
   Google Scholar
• ANNUNZIATO F, COSMI L, LIOTTA F et al.: Phenotype, localization and mechanism of suppression of CD4*CD25* human thymocytes. J. Exp. Med. (2002) 196:379–387.
   PubMed Web of Science ®Google Scholar
• SHEVACH EM: CD4*CD25* suppressor T cells: more questions than answers. Nat. Rev. Immunol (2002) 2:389–400.
   PubMed Web of Science ®Google Scholar
• JORDAN MS, BOESTEANU A. REED AJ et al.: Thymic selection of CD4*CD25* regulatory T cells induced by an agonist self-peptide. Nat. Immunol (2001) 2:301–306.
   Google Scholar
• NISHIBORI T, TANABE Y, SU L, DAVID M: Impaired development of CD4*CD25* regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease./ Exp. Med. (2004) 199:25–34.
   PubMed Web of Science ®Google Scholar
• ANTOV A, YANG L, VIG M, BALTIMORE D, VAN PARIJS L: Essential role for STAT5 signaling in CD25*CD4* regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol (2003) 171:3435–3441.
   PubMed Web of Science ®Google Scholar
• HOYNE GF, LE ROUX I, CORSIN -JIMENEZ M et al.: Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4* T cells. Int. Immunol 2000 12:177–185.
   Google Scholar
• YVON ES, VIGOUROUX S, ROUSSEAU RF et al.: Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood (2003) 102:3815–3821.
   PubMed Web of Science ®Google Scholar
• SHIMIZU J, YAIVIAZAKI S, TAKAHASHI T, ISHIDA Y, SAKAGUCHI S: Stimulation of CD25*CD4* regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. (2002) 3:135–142.
   PubMed Web of Science ®Google Scholar
• BACH JF: Regulatory T cells under scrutiny. Nat. Rev. Immunol (2003) 3:189–198.
   PubMed Web of Science ®Google Scholar
• COZZO C, LARKIN J, CATON AJ: Self-peptides drive the peripheral expansion of CD4*CD25* regulatory T cells. J. Immunol (2003) 171:5678–5682.
   PubMed Web of Science ®Google Scholar
• BRUDER D, PROBST-KEPPER M, WESTENDORF AM et al.: Neuropilin-1: a surface marker of regulatory T cells. Eur. Immunol (2004) 34:623–630.
   PubMed Web of Science ®Google Scholar
• STASSEN M, FONDEL S, BOPP T et al.: Human CD25* regulatory T cells: two subsets defined by the integrins a4137 or a4131 confer distinct suppressive properties upon CD4* T helper cells. Eur. j Immunol (2004) 34:1303–1311.
   PubMed Web of Science ®Google Scholar
• RONCADOR G, BROWN PJ, MAESTRE Let al.: Analysis of FoxP3 protein expression in human CD4*CD25* regulatory T cells at the single-cell level. Eur. J. Immunol (2005) 35:1681–1691.
   Google Scholar
• BRUNKOW ME, JEFFERY EW, HJERRILD KA et al.: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. (2001) 27:68–73.
   PubMed Web of Science ®Google Scholar
• HORT S, NOMURA T, SAKAGUCHI S: Control of regulatory T cell development of the transcription factor FoxP3. Science. (2003) 299:1057–1061.
   PubMed Web of Science ®Google Scholar
• CHEN W, JIN W, HARDEGEN N et aL: Conversion of peripheral CD4*CD25- naive T cells to CD4*CD25* regulatory T cells by TGF-I3 induction of transcription factor FoxP3. J. Exp. Med. (2003) 198:1875–1886.
   PubMed Web of Science ®Google Scholar
• KHATTRI R, COX T, YASAYKO SA, RAMSDELL F: An essential role for scurfin in CD4*CD25* T regulatory cells. Nat. Immunol (2003) 4:337–342.
   PubMed Web of Science ®Google Scholar
• WALKER MR, KASPROWICZ DJ, GERSUK VH et al.: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4*CD25- T cells. J. Clin. Invest. (2003) 112:1437–1443.
   PubMed Web of Science ®Google Scholar
• FONTENOT JD, RASMUSSEN JP, WILLIAMS LM, DOOLEY JL, FARR AG, RUDENSKY AY: Regulatory T cell lineage specification by the forkhead transcription factor FoxP3. Immunity (2005) 22:329–341.
   PubMed Web of Science ®Google Scholar
• ZELENAY S, LOPES-CARVALHO T, CARAMALHO I, MRAES-FONTES MF, REBELO M, DEMENGEOT J: FoxP3*CD25-CD4* T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA (2005) 102:4091–4096.
   PubMed Web of Science ®Google Scholar
• GRACAL: New tools to identify regulatory T cells. Eur. J. Immunol (2005) 35:1678–1680.
   PubMed Web of Science ®Google Scholar
• RONCADOR G, BROWN PJ, MAESTRE Let al.: Analysis of FOXP3 protein expression in human CD4*CD25* regulatory T cells at the single-cell level. Eur. J. Immunol. (2005) 35:1681–1691.
   Google Scholar
• MISRA N, BAYRY J, LACROIX-DESMAZES S, KAZATCHKINE MD, KAVERI SV: Human CD4*CD25* T cells restrain the maturation and antigen-presenting function of dendritic cells. Immunol (2004) 172:4676–4680.
   Web of Science ®Google Scholar
• CEDERBOM L, HALL H, IVANS F: CD4*CD25* regulatory T cells down-regulate costimulatory molecules on antigen-presenting cells. Eur. j Immunol (2000) 30:1538–1543.
   PubMed Web of Science ®Google Scholar
• JONULEIT H, SCHMITT E, KAKIRMAN H, STASSEN M, KNOP J, ENK AH: Infectious tolerance: Human CD25* regulatory T cells convey suppressor activity to conventional CD4* T helper cells./ Exp. Med. (2002) 196:255–260.
   PubMed Web of Science ®Google Scholar
• DIECKMANN D, BRUETT CH, PLOETTNER H, LUTZ MB, SCHULER G: Human CD4*CD25* regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent Type 1-like regulatory T cells. J. Exp. Med. (2002) 196:247–253.
   PubMed Web of Science ®Google Scholar
• NAKAMURA K, KITANI A, STROBERW: Cell contact-dependent immunosuppression by CD4*CD25* regulatory T cells is mediated by cell surface-bound transforming growth factor if Exp. Med. (2001) 194:629–644.
   Web of Science ®Google Scholar
• CHEN W, WAHL SM: TGF: the missing link in CD4*CD25* regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. (2003) 14:85–89.
   PubMed Web of Science ®Google Scholar
• FALLARINO F, GROHMANN U, HWANG KW et al.: Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. (2003) 4:1206–1212.
   PubMed Web of Science ®Google Scholar
• GONDEK DC, LU LF, QUEZADA SA, SAKAGUCHI S, NOELLE RJ: Contact-mediated suppression by CD4*CD25* regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol (2005) 174:1783–1786.
   PubMed Web of Science ®Google Scholar
• GROSSMAN WJ, VERBSKY JW, BARCHET W, COLONNA M, ATKINSON JP, LEY TJ: Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. (2004) 21:589–601.
   PubMed Web of Science ®Google Scholar
• YOU S, BELGHITH M, COBBOLD S et al.: Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T cells. Diabetes. (2005) 54:1415–1422.
   PubMed Web of Science ®Google Scholar
• LEPAULT F, GAGNERAULT MC: Characterization of peripheral regulatory CD4* T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol (2000) 164:240–247.
   PubMed Web of Science ®Google Scholar
• SEDDON B, MASON D: Regulatory Tcells in the control of autoimmunity: the essential role of transforming growth factor 13 and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4*CD45RC- cells and CD4*CD8- thymocytes. J. Exp. Med. (1999) 189:279–288.
   PubMed Web of Science ®Google Scholar
• ASSEMAN C, MAUZE S, LEACH MW, COFFMAN RI,, POWRIE F: An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. (1999) 190:995–1004.
   PubMed Web of Science ®Google Scholar
• POWRIE F, CARLINO J, LEACH MW, MAUZE S, COFFMAN RL: A critical role for transforming growth factor-I3 but not interleukin-4 in the suppression of T helper Type 1-mediated colitis by CD45RBI'gh-CD4* T cells. J. Exp. Med. (1996) 183:2669–2674.
   PubMed Web of Science ®Google Scholar
• SURI-PAYER E, CANTOR H: Differentialcytokine requirements for regulation of autoimmune gastritis and colitis by CD4*CD25* Treg cells. J. Autoimmun. (2001) 16:115–123.
   PubMed Web of Science ®Google Scholar
• AKBARI 0, FREEMAN GJ, MEYER EH et al.: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. (2002) 8:1024–1032.
   Google Scholar
• ZHANG X, KOLDZIC DN, IZIKSON L et al.: IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25*CD4* regulatory T cells. Int. Immunol (2004) 16:249–256.
   PubMed Web of Science ®Google Scholar
• KINGSLEY CI, KARIM M, BUSHELL AR, WOOD KJ: CD25*CD4* regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. Immunol (2002) 168:1080–1086.
   Web of Science ®Google Scholar
• O'GARRA A, VIEIRA P: Regulatory T cells and mechanisms of immune system control. Nat. Med. (2004) 10:801–805.
   PubMed Web of Science ®Google Scholar
• MALOY KJ, SALAUN L, CAHILL R, DOUGAN G, SAUNDERS NJ, POWRIE F: CD4*CD25* Tr cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. (2003) 197:111–119.
   PubMed Web of Science ®Google Scholar
• WAHL SM, SWISHER J, McCARTNEY -FRANCIS N, CHEN W: TGF-13: the perpetrator of immune suppression by regulatory T cells and suicidal T cells] Leuk. BioL (2004) 76:15–24.
   Google Scholar
• PAUST S, CANTOR H: Regulatory T cells and autoimmune disease. Immunol. Rev. (2005) 204:195–207.
   PubMed Web of Science ®Google Scholar
• ••An interesting review on the role of Tregdysfunction in the pathogenesis of autoimmune diseases.
   Google Scholar
• MARIE JC, LETTERIO JJ, GAVIN M, RUDENSKY AY: TGF-131 maintains suppressor function and FoxP3 expression in CD4*CD25* regulatory T cells. J. Exp. Med. (2005) 201:1061–1067.
   PubMed Web of Science ®Google Scholar
• FANTINI MC, BECKER C, MONTELEONE G, PALLONE F, GALLE PR, NEURATH MF: TGF -13 induces a regulatory phenotype in CD4*CD25- T cells through FoxP3 induction and down-regulation of Smad7. Immunol . (2004) 172:5149–5153.
   Web of Science ®Google Scholar
• YAMAGIWA S, GRAY JD, HASHIMOTO S, HORWITZ DA: A role for TGF-13 in the generation and expansion of CD4*CD25* regulatory T cells from human peripheral blood. J. Immunol. (2001) 166:7282–7289.
   PubMed Web of Science ®Google Scholar
• FAHLEN L, READS, GORELIK L et ed: T cells that cannot respond to TGF-13 escape control by CD4*CD25* regulatory T cells. J. Exp. Med. (2005) 201:737–746.
   PubMed Web of Science ®Google Scholar
• NELSON BH: IL-2, regulatory T cells, and tolerance] ImmunoL (2004) 172:3983–3988.
   Google Scholar
• MALEK TR, BAYER AL: Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. (2004) 4:665–674.
   PubMed Web of Science ®Google Scholar
• ••A fundamental review on the role of IL-2in Treg cell biology.
   Google Scholar
• THORNTON AM, DONOVAN EE, PICCIRILLO CA, SHEVACH EM: IL-2 is critically required for the in vitro activation of CD4*CD25* T cell suppressor function. Immunol . (2004) 172:6519–6523.
   Web of Science ®Google Scholar
• SETOGUCHI R, HOPI S, TAKAHASHI T, SAKAGUCHI S: Homeostatic maintenance of natural FoxP3*CD25*CD4* regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp. Med. (2005) 201:723–735.
   PubMed Web of Science ®Google Scholar
• SARWEEN N, CHODOS A, RAYKUNDALIA C et aL: CD4*CD25* cells controlling a pathogenic CD4 response inhibit cyrokine differentiation, CXCR-3 expression and tissue invasion. J. Immunol. (2004) 173:2942–2951.
   PubMed Web of Science ®Google Scholar
• LEHMANN J, HUEHN J, DE LA ROSA M et al.: Expression of the integrin (1E137 identifies unique subsets of CD25* as well as CD25- regulatory T cells. Proc. Nail. Acad. Sci. USA (2002) 99:13031–13036.
   Google Scholar
• IELLEM A, MARIANI M, LANG R et al.:Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4*CD25* regulatory T cells. J. Exp. Med. (2001) 194:847–853.
   PubMed Web of Science ®Google Scholar
• PAPADAKIS KA, LANDERS C, PREHN J et al.: CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and TH1 or T-regulatory 1 cytokine profile. J. Immunol. (2003) 171:159–165.
   PubMed Web of Science ®Google Scholar
• DENNING TL, KIM G, KRONENBERG M: CD4*CD25* regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. (2005) 174:7487–7491.
   PubMed Web of Science ®Google Scholar
• GROUX H: Type 1 T regulatory cells: Their role in the control of immune responses. Transplantation (2003) 75:8S–12S.
   Google Scholar
• BARRAT FJ, CUA DJ, BOONSTRA A et al.: In vitro generation of interleukin 10-producing regulatory CD4* T cells is induced by immunosuppressive drugs and inhibited by T helper Type 1 (TH1)- and Th2-inducing cytokines. J. Exp. Med. (2002) 195:603–616.
   PubMed Web of Science ®Google Scholar
• GRACA L, COBBOLD SP, WALDMANN : Identification of regulatory T cells in tolerated allografts. J. Exp. Med. (2002) 195:1641–1646.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, RUMI C, SICA S, LEONE G: Recombinant human granulocyte colony-stimulating factor (rhG-CSF): effects on lymphocyte phenotype and function. J. Interf Cytok. Res. (1999) 19:989–994.
   PubMed Web of Science ®Google Scholar
• VOLPI I, PERRUCCIO K, TOSTI A et aL:Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood. (2001) 97:2514–2521.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, PIERELLI L, RUMI Get aL:T-cell apoptosis induced by granulocyte colony-stimulating factor (G-CSF) is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp. HematoL (2001) 29:401–415.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, RUMI C, LUCIA MB, SICA S, CAUDA R, LEONE G: Serum of healthy donors receiving recombinant human granulocyte colony-stimulating factor (rhG-CSF) induces T-cell unresponsiveness. Exp. HematoL (1998) 26:1024–1033.
   PubMed Web of Science ®Google Scholar
• FRANZKE A, PIAO W, LAUBER J et aL: G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood (2003) 102:734–739.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, PIERELLI L, BONANNO G et aL: Role for granulocyte colony-stimulating factor in the generation of human T regulatory Type 1 cells. Blood (2002) 100:2562–2571.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, BONANNO G, PIERELLI Let aL: Granulocyte colony-stimulating factor promotes the generation of regulatory DCs through induction of IL-10 and IFN-a. Eur. J. Immunol. (2004) 34:1291–1302.
   PubMed Web of Science ®Google Scholar
• MORRIS ES, MACDONALD KPA, ROWE Vet aL: Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood (2004) 103:3573–3581.
   PubMed Web of Science ®Google Scholar
• FAUNCE DE, TERAJEWICZ A, STEIN-STREILEIN J: In vitro-generated tolerogenic APC induce CD8* T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. Immunol . (2004) 172:1991–1995.
   Web of Science ®Google Scholar
• KOHM AP, CARPENTIER PA, ANGER HA, MILLER SD: CD4*CD25* regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. (2002) 169:4712–4716.
   PubMed Web of Science ®Google Scholar
• HAFLER DA, SLAVIK JM, ANDERSON DE, O'CONNOR KC, DE JAGER P, BEACHER-ALLAN C: Multiple sclerosis. Immunol. Rev. (2005) 204:208–231.
   PubMed Web of Science ®Google Scholar
• •An updated and comprehensive paper on MS.
   Google Scholar
• VIGLIETTA V, BAECHER-ALLAN C, WEINER HL, HAFLER DA: Loss of functional suppression by CD4*CD25* regulatory T cells in patients with multiple sclerosis. J. Exp. Med. (2004) 199:971–979.
   PubMed Web of Science ®Google Scholar
• HONG J, LI N, ZHANG X, ZHENG B, ZHANG JZ: Induction of CD4*CD25* regulatory T cells by copolimer-I through activation of transcription factor FoxP3. Proc. Natl. Acad. Sci. USA (2005) 102:6449–6454.
   PubMed Web of Science ®Google Scholar
• MIURA Y, THOBURN CJ, BRIGHT EC et al.: Association of FoxP3 regulatory gene expression with graft-versus-host disease. Blood. (2004) 104:2187–2193.
   PubMed Web of Science ®Google Scholar
• CLARK FJ, GREGG R, PIPER K et al.: Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4*CD2511'gh regulatory T cells. Blood (2004) 103:2410–2416.
   PubMed Web of Science ®Google Scholar
• ZORN E, KIM HT, LEE SJ et al.: Reduced frequency of FOXP3*CD4*CD25* regulatory T cells in patients with chronic graft-versus-host disease. Blood (2005) 106:2903–2911.
   PubMed Web of Science ®Google Scholar
• MONK CR, SPACHIDOU M, ROWS F et al.: MRL/Mp CD4*CD25- T cells show reduced sensitivity to suppression by CD4*CD25* regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arth. Rheum. (2005) 52:1180–1184.
   PubMed Web of Science ®Google Scholar
• BAGAVANT H, TUNG KS: Failure of CD25* T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J. Immunol. (2005) 175:944–950.
   PubMed Web of Science ®Google Scholar
• WU HY, STAINES NA: A deficiency of CD4*CD25* T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus (2004) 13:192–200.
   PubMed Web of Science ®Google Scholar
• LIU MF, WANG CR, FUNG LL, WU CR: Decreased CD4*CD25* T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. j Immunol. (2004) 59:198–202.
   PubMed Web of Science ®Google Scholar
• HORWITZ DA, GRAY JD, ZHENG SG: The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res. (2002) 4:241–246.
   PubMedGoogle Scholar
• FIOCCHI C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 115:182–205.
   PubMed Web of Science ®Google Scholar
• ALLEZ M, MAYER L: Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. (2004) 10:666–676.
   PubMed Web of Science ®Google Scholar
• POWRIE F, MASON D: OX-22h'ghCD4* T cells induce wasting disease with multiple organ pathology: prevention by the OX-2210v' subset. J. Exp. Med. (1990) 172:1701–1708.
   PubMed Web of Science ®Google Scholar
• STEINMAN RM, HAWIGER D, NUSSENZWEIG MC: Tolerogenic dendritic cells. Ann. Rev. Immunol. (2003) 21:685–711.
   PubMed Web of Science ®Google Scholar
• DE WINTER H, ELEWAUT D, TUROVSKAYA 0 et al.: Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology (2002) 122:1829–1841.
   Google Scholar
• BARRAT FJ, CUA DJ, BOONSTRA A et al.: In vitro generation of interleukin 10-producing regulatory CD4* T cells is induced by immunosuppressive drugs and inhibited by T helper Type 1 (TH1)- and Th2-inducing cytokines. J. Exp. Med. (2002) 195:603–616.
   PubMed Web of Science ®Google Scholar
• CONG Y, WEAVER CT, LAZENBY A, ELSON CO.: Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. (2002) 169:6112–6119.
   Google Scholar
• WAIDMANN M, ALLEMAND Y, LEHMANN Jet aL: Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-y and TNF-a production. Gut. (2002) 50:170–179.
   PubMed Web of Science ®Google Scholar
• KULLBERG MC, JANKOVIC D, GORELICK PL et al.: Bacteria-triggered CD4* T regulatory cells suppress helicobacter hepaticus-induced colitis. J. Exp. Med. (2002) 196:505–515.
   PubMed Web of Science ®Google Scholar
• NEURATH MF, FUSS I, KELSALL BL, PRESKY DH, WAEGELL W, STROBERW: Experimental granulomatous colitis in mice is abrogated by induction of TGF-13-mediated oral tolerance. J. Exp. Med. (1996) 183:2605–2616.
   PubMed Web of Science ®Google Scholar
• FUSS IJ, BOIRIVANT M, LACY B, STROBER W: The interrelated roles of TGF-13 and IL-10 in the regulation of experimental colitis. J. Immunol. (2002) 168:900–908.
   PubMed Web of Science ®Google Scholar
• BOIRIVANT M, FUSS IJ, CHU A, STROBER W: Oxazolone colitis: a murine model of T helper cell Type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. (1998) 188:1929–1939.
   PubMed Web of Science ®Google Scholar
• MAKITA S, KANAI T, OSHIMA S et al.: CD4*CD25b"gh' T cells in human intestinal lamina propria as regulatory cells. Immunol . (2004) 173:3119–3130.
   Web of Science ®Google Scholar
• MAUL J, LODDENKEMPER C, MUNDT P et al.: Peripheral and intestinal regulatory CD4*CD2511'gh T cells in inflammatory bowel disease. Gastroenterology (2005) 128: 1868-1878.
   Google Scholar
• MOTTET C, UHLIG HH, POWRIE F: Cure of colitis by CD4*CD25* regulatory T cells. J. Immunol. (2003) 170:3939–3943.
   PubMed Web of Science ®Google Scholar
• POP SM, WONG CP, CULTON DA, CLARKE SH, TISCH R: Single cell analysis shows decreasing FoxP3 and TGF-131 coexpressing CD4*CD25* regulatory T cells during autoimmune diabetes. J. Exp. Med. (2005) 201:1333–1346.
   PubMed Web of Science ®Google Scholar
• GREEN EA, CHOI Y, FLAVELL RA: Pancreatin lymph node-derived CD4*CD25* Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity (2002) 16:183–191.
   PubMed Web of Science ®Google Scholar
• LINDLEY S, DAYAN CM, BISHOP A, ROEP BO, PEAKMAN M, TREE TIM: Defective suppressor function in CD4*CD25* T cells from patients with Type 1 diabetes. Diabetes (2005) 54:92–99.
   PubMed Web of Science ®Google Scholar
• KARED H, MASSON A, ADLE-BIASSETTE H, BACH JF, CHATENOUD L, ZAVALA F: Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4*CD25* regulatory T cells. Diabetes (2005) 54:78–84.
   PubMed Web of Science ®Google Scholar
• VELDMAN C, HOHNE A, DIECKMANN D, SCHULER G, HERTL M: Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. Immunol . (2004) 172:6468–6475.
   Web of Science ®Google Scholar
• MQADMI A, ZHENG X, YAZDANBAKHSH K: CD4*CD25* regulatory T cells control induction of autoimmune hemolytic anemia. Blood (2005) 105:3746–3748.
   PubMed Web of Science ®Google Scholar
• SUGIYAMA H, GYULAI R, TOICHI E et al.: Dysfunctional blood and target tissue CD4*CD25h'gh regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. (2005) 174:164–173.
   PubMed Web of Science ®Google Scholar
• KRIEGEL MA, LOHMANN T, GABLER C, BLANK N, KALDEN JR, LORENZ HM: Defective suppressor function of human CD4*CD25* regulatory T cells in autoimmune polyglandular syndrome Type II. J. Exp. Med. (2004) 199:1285–1291.
   PubMed Web of Science ®Google Scholar
• GAO D, MALMSTROM V, BAECHER-ALLAN C, HAFLER D, KLARESKOG L, TROLLMO C: Isolation and functional characterization of regulatory CD25b"gh'CD4* T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. (2003) 33:215H223.
   Web of Science ®Google Scholar
• DE KLEER IM, WEDDERBURN LR, TAAMS LS et al.: CD4*CD25br'gh' regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. (2004) 172:6435–6443.
   PubMed Web of Science ®Google Scholar
• VASU C, DOGAN RN, HOLTERMAN MJ, PRABHAKAR BS: Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4*CD25* T cells and suppresses experimental autoimmune thyroiditis. lirtmund (2003) 170:5511–5522.
   Google Scholar
• GANGI E, VASU C, CHEATEM D, PRABHAKAR BS: IL-10-producing CD4*CD25* regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. (2005) 174:7006–7013.
   PubMed Web of Science ®Google Scholar
• VERGINIS P, LI HS, CARAYANNIOTIS G: Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4*CD25* T cells. J ImmunoL (2005) 174:7433–7439.
   PubMed Web of Science ®Google Scholar
• BALANDINA A, LECART S, DARTEVELLE P, SAOUDI A, BERRIH-AKNIN S: Functional defect of regulatory CD4*CD25* T cells in the thymus of patients with autoimmune myasthenia gravis. Blood (2005) 105:735–741.
   PubMed Web of Science ®Google Scholar
• GAMBINERI E, TORGERSON TR, OCHS HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. RheumatoL (2003) 15:430–435.
   PubMed Web of Science ®Google Scholar
• BENNETT CL, CHRISTIE J, RAMSDELL F et al.: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genetics (2001) 27:20–21.
   PubMed Web of Science ®Google Scholar
• BAUD 0, GOULET 0, CANIONI D et al.: Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. New EngL J. Med. (2001) 344:1758–1762.
   Google Scholar
• MAZZOLARI E, FORINO C, FONTANA M et al.: A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant. (2005) 35:1033–1034.
   PubMed Web of Science ®Google Scholar
• OCHS HD, ZIEGLER SF, TORGERSON TR: FOXP3 acts as a rheostat of the immune response. Immunol. Rev. (2005) 203:156–164.
   PubMed Web of Science ®Google Scholar
• SMYK-PEARSON SK, BAKKE AC, HELD PK, WILDIN RS: Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-entiched splenocytes. Clin. Exp. Immunol. (2003) 133:193–199.
   PubMed Web of Science ®Google Scholar
• BACCHETTA R, SARTIRANA C, LEVINGS MK, BORDIGNON C, NARULA S, RONCAROLO MG: Growth and expansion of human T regulatory Type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. j Immunol. (2002) 32:2237–2245.
   PubMed Web of Science ®Google Scholar
• FOUSSAT A, COTTREZ F, BRUN V, FOURNIER N, BREITTMAYER JP, GROUX H: A comparative study between T regulatory Type 1 and CD4*CD25* T cells in the control of inflammation. J. Immunol. (2003) 171:5018–5026.
   PubMed Web of Science ®Google Scholar
• HOFFMANN P, EDER R, KUNZ-SCHUGHART LA, ANDREESEN R, EDINGER M: Large-scale in vitro expansion of polyclonal CD4*CD25high regulatory T cells. Blood (2004) 104:895–903.
   PubMed Web of Science ®Google Scholar
• TANG Q, HENRIKSEN KJ, BI M et al.: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. (2004) 199:1455–1465.
   PubMed Web of Science ®Google Scholar
• BLUESTONE JA, TANG Q: Therapeutic vaccination using CD4*CD25* antigen-specific regulatory T cells. Proc. Nail. Acad. Sci. USA (2004) 101:14622–14626.
   PubMed Web of Science ®Google Scholar
• COHEN JL, TRENADO A, VASEY D, KLATZMANN D, SALOMON BL: CD4*CD25* immunoregulatory T cells: New therapeutics for graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. (2002) 196:401–406.
   PubMed Web of Science ®Google Scholar
• TAYLOR PA, LEES CJ, BLAZAR BR: The infusion of ex vivo activated and expanded CD4*CD25* immune regulatory cells inhibits graft-versus-host disease lethality. Blood. (2002) 99:3493–3499.
   PubMed Web of Science ®Google Scholar
• HOFFMANN P, ERMANN J, EDINGER M, FATHMAN CG, STROBER S: Donor-type CD4*CD25* regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation./ Exp. Med. (2002) 196:389–399.
   PubMed Web of Science ®Google Scholar
• EDINGER M, HOFFMAN P, ERMANN J et al.: CD4*CD25* regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. (2003) 9:1144–1150.
   PubMed Web of Science ®Google Scholar
• TRENADO A, CHARLOTTE F, FISSON S et al.: Recipient-type specific CD4*CD25* regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. (2003) 112:1688–1696.
   PubMed Web of Science ®Google Scholar
• SATO K, YAIVIASHITA N, YAMASHITA N, MASANORI B, MATSUYAMA T: Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity (2003) 18:367–379.
   PubMed Web of Science ®Google Scholar
• SATO K, YAMASHITA N, BABA M, MATSUYAMA T: Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood (2003) 101:3581–3589.
   PubMed Web of Science ®Google Scholar
• MILLS KH: Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. (2004) 4:1–15.
   Google Scholar
• TERABE M, BERZOFSKY JA: Immunoregulatory T cells in tumor immunity. Curr. Opin. Immunol. (2004) 16:157–162.
   PubMed Web of Science ®Google Scholar
• CURIEL TJ, COUKOS G, LINHUA Z et al.: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. (2004) 10:942–949.
   PubMed Web of Science ®Google Scholar
• WOLF AM, WOLF D, STEURER M, GASTL G, GUNSILIUS E, GRUBECK-LOEBENSTEIN B: Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. (2003) 9:606–612.
   PubMed Web of Science ®Google Scholar
• NISHIKAWA H, JAGER E, RITTER G, OLD LJ, GNJATIC S: CD4*CD25* regulatory T cells control the induction of antigen-specific CD4'helper T cell responses in cancer patients. Blood (2005) 106:1008–1011.
   PubMed Web of Science ®Google Scholar
• SHARMA S, YANG S, ZHU Let aL: Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4*CD25* T regulatory cell activities in lung cancer. Cancer Res. (2005) 65:5211–5220.
   PubMed Web of Science ®Google Scholar
• KARUBE K, OHSHIMA K, TSUCHIYA T et aL: Expression of FoxP3, a key molecule in CD4*CD25* regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. HaematoL (2004) 126:81–84.
   PubMed Web of Science ®Google Scholar
• ISHIDA T, IIDA S, AKATSUKA Yet aL: The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin. Cancer Res. (2004) 10:7529–7539.
   PubMed Web of Science ®Google Scholar
• RUTELLA S, RUMI C, TESTA U et al.: Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant. (1997) 20:355–364.
   PubMed Web of Science ®Google Scholar
• MALOY KJ, POWRIE F: Regulatory T cells in the control of immune pathology. Nat. Immunol. (2001) 2:816–822.
   PubMed Web of Science ®Google Scholar
• WOOD KJ, SAKAGUCHI S: Regulatory T cells in transplantation tolerance. Nat. Rev. ImmunoL (2003) 3:199–210.
   PubMed Web of Science ®Google Scholar
• LEVINGS MK, SANGREGORIO R, RONCAROLO MG: Human CD4*CD25* T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. (2001) 193:1295–1302.
   PubMed Web of Science ®Google Scholar
• KANAI T, WATANABE M: Clinical application of human CD4*CD25* regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opin. Biol. Ther. (2005) 5:451–462.
   PubMed Web of Science ®Google Scholar
• BAECHER-ALLAN C, WOLF E, HAFLER DA: Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4*CD25*T cells. Clin. ImmunoL (2005) 115:10–18.
   PubMed Web of Science ®Google Scholar
• BAAN CC, VAN DER MAST BJ, KLEPPER M et al.: Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FoxP3 in human T cells. Transplantation (2005) 80:110–117.
   Google Scholar
• BATTAGLIA M, STABILINI A, RONCAROLO MG: Rapamycin selectively expands CD4*CD25*FoxP3* regulatory T cells. Blood (2005) 105:4743–4748.
   PubMed Web of Science ®Google Scholar
• ZHENG XX, SANCHEZ-FUEYO A, SHO M, DOMENIG C, SAYEGH MH, STROM TB: Favorably tipping the balance between cytophatic and regulatory T cells to create transplantation tolerance. Immunity (2003) 19:503–514.
   PubMed Web of Science ®Google Scholar